Popular Brachytherapy News and Current Events | Page 2

Popular Brachytherapy News and Current Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Recent
Page 2 of 6 | 224 Results
ASTRO publishes evidence-based guideline for thoracic radiotherapy
The American Society for Radiation Oncology (ASTRO) has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO. (2011-04-27)

Family history of prostate cancer does not affect some treatment outcomes
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy, also called seed implants, and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a Jan. 1 study in the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology. (2009-01-02)

Brachytherapy proves effective in treating skin cancer
The use of high-dose-rate brachytherapy to treat elderly patients with common skin cancers offers excellent cure rates and cosmetic outcomes, according to a new study. (2019-12-04)

Study finds brachytherapy offers lower rate of breast preservation compared to standard radiation for older women with breast cancer
When comparing treatments designed to enable long-term breast preservation for older women with invasive breast cancer, researchers found those treated with brachytherapy were at higher risk for a later mastectomy, compared to women treated with standard radiation therapy. The research was led by The University of Texas MD Anderson Cancer Center. (2014-01-30)

Quality of life returns to normal in year following brachytherapy
In the first study of its type, Wake Forest University investigators reported today (May 3) that the quality of life for prostate cancer patients returns to normal within one year after implantation ofpermanent-source brachytherapy, and symptoms essentially disappear. (2000-05-03)

Combined treatment extends life expectancy for lung cancer patients
By combining radiation and thermal ablation for treatment of lung cancer, patients lived longer and had fewer recurrences. (2006-07-17)

Radiation therapy combo cures prostate cancer long-term
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO. (2007-01-04)

What is ESTRO 33? ESTRO 33 will feature new research results in clinical radiation oncology, radiobiology, physics, technology, and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. The conference is expected to attract 3700 delegates from more than 80 countries. (2014-01-30)

Proton therapy effective prostate cancer treatment
Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology•Biology•Physics, the American Society for Radiation Oncology's official scientific journal. (2012-01-05)

Study examines prostate cancer treatment decisions
A five-year follow-up study of more than 2,000 US men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care. (2020-01-27)

Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Patients with low haemoglobin levels in their tumors do not respond well to radiotherapy, but now Dutch researchers have found that combining accelerated radiotherapy with a mixture of carbon dioxide and oxygen and the vitamin nicotinamide can overcome this problem in head and neck cancer. Use of the combination treatment meant that the differences in outcome between patients with low haemoglobin levels and those with normal levels were no longer significant. (2012-05-10)

Hormone therapy for prostate cancer may increase risk of depression
A new study led by researchers at Brigham and Women's Hospital has found a significant association between depression and patients being treated for localized prostate cancer by androgen deprivation therapy. (2016-04-11)

Hormone therapy may be hazardous for men with heart conditions
Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of ASTRO. (2011-07-26)

Aesthetics of skin cancer therapy may vary by treatment type
In a meta-analysis of 58 studies, a study led by Penn State compared four types of skin cancer treatments and found that while all four had similar recurrence rates a year after treatment, a form of radiation called brachytherapy and a type of surgery called Mohs micrographic surgery had better cosmetic results. (2019-09-03)

Cervical cancer survival may improve by targeting senescent "zombie" cells
How well women with cervical cancer respond to treatment and survive correlates with the level of 10 proteins in their blood that also are associated with a ''zombie'' cell state called senescence, Medical College of Georgia scientists report. (2020-12-07)

ASTRO president speaks on prostate cancer at MEDCAC meeting
ASTRO President Anthony Zietman, M.D., spoke before the Medicare Evidence Development and Coverage Advisory Committee meeting today on radiation therapy for treatment of localized prostate cancer. MEDCAC provides advice and recommendations to the Centers for Medicare and Medicaid Services for what is covered by Medicare and Medicaid, based on scientific evidence. Today's meeting focused on the risks, benefits and outcomes of radiation therapy treatments for localized prostate cancer as compared with watchful waiting. (2010-04-21)

Radiation may provide a new ray of hope for an old problem
Radiation has long been used as a method for killing cancer cells. Now researchers say radiation looks promising as a way to kill the overgrowth of tissue cells that can lead to a reblockage of a heart artery, according to a report in today's issue of Circulation: Journal of the American Heart Association. (2000-01-30)

Special edition of the Red Journal highlights the need for radiation oncology services in LMICs
The July 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics, the official scientific journal of the American Society for Radiation Oncology, features a special section of 10 articles focusing on global health and radiation oncology in low- and middle-income countries. (2014-06-25)

African-American men negatively impacted by hormone therapy for treatment of prostate cancer
In a retrospective study analyzing patients' medical records, researchers at Brigham and Women's Hospital found that patients' race significantly affected their longevity by increasing the likelihood of death after receiving androgen deprivation therapy. (2016-08-04)

Extended outcomes from APBI show tumor control, breast cosmesis and minimal late toxicity
Long-term (five-year) outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation (APBI) after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the Feb. 1, 2014, print edition of the International Journal of Radiation Oncology*Biology*Physics, the official scientific journal of the American Society for Radiation Oncology. (2014-01-29)

EBRT reduces risk of subsequent mastectomy in patients with invasive breast cancer
Standard external beam radiation therapy (EBRT) provided a higher breast preservation rate than brachytherapy in women age 66 and older with invasive breast cancer, according to a study published in the Feb. 1, 2014, print edition of the International Journal of Radiation Oncology*Biology*Physics, the official scientific journal of the American Society for Radiation Oncology. (2014-01-29)

Report suggests similar effectiveness among options for managing low-risk prostate cancer
A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably. The report was prepared by the Institute for Clinical and Economic Review, a leader in comparative effectiveness research based at the Massachusetts General Hospital's Institute for Technology Assessment. (2010-01-05)

Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes
The use of permanent brachytherapy, a procedure where radioactive sources are placed inside the prostate, into or near to the tumor, preserves erectile function in approximately 50 percent of patients with prostate cancer. Brachytherapy used alone is as effective as other established therapies for localized low to intermediate risk prostate cancer. (2014-04-04)

New model may simplify high-dose radiosurgery planning
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncology researchers at Ohio State University may have solved the problem with a new mathematical model called the Generalized LQ (gLQ) Model that encompasses all dose levels and schedules. (2010-09-02)

Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis
A team of Emory cardiology researchers presented a study at the American College of Cardiology (ACC) Scientific Sessions today showing that patients with in-stent restenosis treated with a sirolimus-eluting stent (SES), which releases the therapeutic agent sirolimus over time to prevent restenosis, fared at least as well as those treated with vascular brachytherapy (VB). Moreover, the patients who received the drug eluting stent had fewer cardiac events afterwards. (2005-03-07)

Combined brachytherapy techniques should be 'benchmark' for cervical cancer treatment
The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers higher radiation doses to the tumor without an increase in treatment-related problems afterwards. The presentation at the 3rd Forum of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona suggests that the technique should be the 'benchmark' for treatment of the disease. (2015-04-24)

Permanent radiotherapy implants reduce risk of prostate cancer recurrence after 5 years
Results from a randomized controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. The research will be presented at the 3rd ESTRO Forum in Barcelona, Spain. (2015-04-26)

Patients report fewer moderate and serious side effects with IMRT than with brachytherapy
In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT. (2006-11-07)

Reliable pretreatment information assists prostate cancer patients in decision-making
Men who have been diagnosed with prostate cancer need to assimilate information rapidly in order to weigh the treatment options and make informed decisions. Although patients consult a variety of information sources, outcome information that is specific to the treating physician leads to greater patient satisfaction following treatment, according to a new study published in The Journal of Urology®. (2014-03-03)

Optimizing brachytherapy dose on the same day as the implant can control prostate cancer
Ensuring the optimum radiation dose on the same day as the brachytherapy implant in prostate cancer treatment manages to control the illness in about 95 percent of the cases. This is the result of research undertaken at the University Hospital of Navarre. (2010-06-23)

New insights into side effects can help prostate cancer patients choose treatments
A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects for modern-day prostate cancer treatments that patients could use to guide their choices. (2017-03-21)

Older women with breast cancer report better cosmetic satisfaction with less radiation, less surgery
In the first study evaluating patient-reported cosmetic outcomes in a population-based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long-term. (2016-12-09)

ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer
The American Society for Radiation Oncology (ASTRO) has issued a new guideline, 'The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,' that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. (2014-04-23)

Breast-saving technique also decreases treatment time
Breast brachytherapy is a breast-conserving technique that also decreases a woman's treatment time from six or seven weeks to just four or five days. Clinical studies show that breast conservation therapy offers the same cure rate as mastectomy for eligible patients. Recent brachytherapy research outcomes show a low 3 to 4 percent disease recurrence rate in the breast. (2004-07-22)

Researcher finds revolutionary way to treat eye cancer
A University of Colorado researcher recently discovered an eye cancer treatment that may prevent blindness. (2010-08-27)

Radiation and immunotherapy combination can destroy both primary and secondary tumors
Research to be presented to the ESTRO 35 conference today has shown that the addition of an immune system-strengthening compound to radiation therapy can extend the radiation therapy-induced immune response against the tumor sites and that this response even has an effect on tumors outside the radiation field. (2016-04-30)

An invitation to Europe's largest forum on radiation oncology
ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. (2012-04-04)

Computerized tool helps predict outcome of treatment for early stage prostate cancer
Researchers at Memorial Sloan-Kettering Cancer Center have pioneered the use of computerized devices to help patients and their physicians decide among the major treatment choices for early stage prostate cancer. Such tools, called nomograms, have been developed to predict outcomes for surgery and radiation therapy, and now, brachytherapy (radioactive seed implantations) for early stage prostate cancer. (2001-09-11)

BUSM study shows chemoradiotherapy prior to surgery improves survival
Researchers from Boston University School of Medicine have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. (2011-02-28)

Sirolimus-releasing stents more effective than VBT for treating restenosis within a stent
David R. Holmes, Jr., MD, of Mayo Clinic, Rochester, Minn., and colleagues with the SISR trial compared the use of vascular brachytherapy (VBT - intra-coronary radiation therapy) with implantation of the sirolimus-eluting stent for the treatment of restenosis occurring within a previously placed bare-metal stent, in a study appearing in the March 15 issue of JAMA. Data on the relative merits of each approach are limited. (2006-03-12)

Page 2 of 6 | 224 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.